IP Verse

Bioregenx, Inc. v. Glycocheck US - 2:25-cv-02071

Bioregenx, Inc. v. Glycocheck US (Case No. 2:25-cv-02071), filed on Oct 24, 2025 in the District Court, D. Nevada involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
2:25-cv-02071
Filing Date
Oct 24, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Nevada
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
GLYCOCALYX RESEARCH INSTITUTE -
Bioregenx, Inc. -
Glycocheck US -
RNL LONEPEAK HOLDINGS, LLC -
GENESIS HEALTH SCIENCES -
HANS VINK BEHEER B.V., -
Microvascular Health Solutions, LLC -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 24, 2025COMPLAINT against All Defendants (Filing fee $405 receipt number ANVDC-8225716) by Bioregenx, Inc., Microvascular Health Solutions, LLC. Certificate of Interested Parties due by 11/3/2025. Proof of service due by 1/22/2026. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5) (Knecht, Adam) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 10/24/2025)PACER Document
Oct 24, 2025NOTICE Rule 7.1 Disclosure Statement by Bioregenx, Inc., Microvascular Health Solutions, LLC re 1 Complaint,,. (Knecht, Adam) (Entered: 10/24/2025)PACER Document
Oct 24, 2025COMPLAINT against All Defendants (Filing fee $405 receipt number ANVDC-8225716) by Bioregenx, Inc., Microvascular Health Solutions, LLC. Certificate of Interested Parties due by 11/3/2025. Proof of service due by 1/22/2026. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5) (Knecht, Adam) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 10/24/2025)Attachment
Oct 24, 2025COMPLAINT against All Defendants (Filing fee $405 receipt number ANVDC-8225716) by Bioregenx, Inc., Microvascular Health Solutions, LLC. Certificate of Interested Parties due by 11/3/2025. Proof of service due by 1/22/2026. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5) (Knecht, Adam) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 10/24/2025)Attachment
Oct 24, 2025COMPLAINT against All Defendants (Filing fee $405 receipt number ANVDC-8225716) by Bioregenx, Inc., Microvascular Health Solutions, LLC. Certificate of Interested Parties due by 11/3/2025. Proof of service due by 1/22/2026. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5) (Knecht, Adam) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 10/24/2025)Attachment
Oct 24, 2025COMPLAINT against All Defendants (Filing fee $405 receipt number ANVDC-8225716) by Bioregenx, Inc., Microvascular Health Solutions, LLC. Certificate of Interested Parties due by 11/3/2025. Proof of service due by 1/22/2026. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5) (Knecht, Adam) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 10/24/2025)Attachment
Oct 24, 2025COMPLAINT against All Defendants (Filing fee $405 receipt number ANVDC-8225716) by Bioregenx, Inc., Microvascular Health Solutions, LLC. Certificate of Interested Parties due by 11/3/2025. Proof of service due by 1/22/2026. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5) (Knecht, Adam) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 10/24/2025)Attachment
Oct 24, 2025COMPLAINT against All Defendants (Filing fee $405 receipt number ANVDC-8225716) by Bioregenx, Inc., Microvascular Health Solutions, LLC. Certificate of Interested Parties due by 11/3/2025. Proof of service due by 1/22/2026. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5) (Knecht, Adam) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 10/24/2025)Attachment